Lori E Fantry
Overview
Explore the profile of Lori E Fantry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grinspoon S, Zanni M, Triant V, Kantor A, Umbleja T, Diggs M, et al.
Lancet HIV
. 2025 Jan;
12(2):e118-e129.
PMID: 39832519
Background: Risk estimation is an essential component of cardiovascular disease prevention among people with HIV. We aimed to characterise how well atherosclerotic cardiovascular disease (ASCVD) risk scores used in clinical...
2.
deMontigny Avila D, Rabe B, Aravagiri A, Joseph M, Lim J, Naveed M, et al.
Sex Transm Dis
. 2024 Dec;
PMID: 39673505
Background: Most Neisseria gonorrhoea (GC) and Chlamydia trachomatis (CT) infections in men who have sex with men (MSM) are diagnosed at extragenital sites. However, testing at these sites is often...
3.
Burrowes S, Zisman E, Fantry L, Bui Q, Wu A, Sorkin J, et al.
Cardiology
. 2024 Aug;
:1-9.
PMID: 39106839
Introduction: People with HIV (PWH) have an increased risk of atherosclerotic cardiovascular disease (ASCVD) compared to non-PWH, but the reasons for this increased risk remain elusive. We investigated the change...
4.
Watanabe M, Davidson L, Smith P, Castellucio P, Jergovic M, Uhrlaub J, et al.
Geroscience
. 2024 Mar;
46(5):4225-4242.
PMID: 38512581
Human cytomegalovirus (hCMV) is a ubiquitous latent persistent herpesvirus infecting 60-90% of the population worldwide. hCMV carriage in immunocompetent people is asymptomatic; thus, hCMV can be considered a component of...
5.
York L, Fisher J, Malladi L, August J, Ellis K, Marquez J, et al.
AIDS Res Hum Retroviruses
. 2021 Feb;
37(4):297-303.
PMID: 33567992
In the era of COVID-19, providers are delaying laboratory testing in people with HIV (PWH). The purpose of this study was to examine the clinical significance of renal, liver, and...
6.
Shende T, Fisher J, Perez-Velez C, Guido A, Sprowl K, Drake T, et al.
J Community Health
. 2019 Oct;
45(2):400-406.
PMID: 31612368
HIV pre-exposure prophylaxis (PrEP) is underutilized among Hispanics, women, and low-income individuals. To better understand PrEP barriers in this population, questionnaires were administered to 500 patients attending public health clinics...
7.
8.
Bagchi S, Burrowes S, Fantry L, Hossain M, Tollera G, Kottilil S, et al.
SAGE Open Med
. 2017 Aug;
5:2050312117725644.
PMID: 28839941
Objective: To determine factors associated with increased risk of developing cardiovascular disease in a high-risk patient population. Design: Cross-sectional analysis of a retrospective cohort study. Methods: One-hundred patients at an...
9.
Fantry L, Nowak R, Fisher L, Cullen N, Yimgang D, Stafford K, et al.
AIDS Res Hum Retroviruses
. 2016 Jun;
32(9):860-7.
PMID: 27329286
Introduction: As HIV-infected patients live longer, non-AIDS-defining cancers are now a major cause of morbidity and mortality. The purpose of this study was to compare the prevalence, type, and location...
10.
Fisher L, Stafford K, Fantry L, Gilliam B, Riedel D
J Cancer Educ
. 2014 Aug;
30(2):319-26.
PMID: 25138982
HIV-infected patients frequently present with advanced stage cancer. It is possible that late stage presentation may be related to lack of cancer knowledge and/or barriers to care. Questionnaires were administered...